Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
Conditions
Interventions
DR30206
Locations
1
China
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Start Date
November 27, 2023
Primary Completion Date
July 30, 2027
Completion Date
September 30, 2027
Last Updated
April 27, 2026
NCT04570423
NCT07489378
NCT07177937
NCT05919264
NCT07181681
NCT06257264
Lead Sponsor
Zhejiang Doer Biologics Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions